T-Cell-Targeted Biologicals for Psoriasis

E-ISSN： 1875-5933|3|2|157-161

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.2, 2004-06, pp. : 157-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antigen-based T-cell-targeted immunotherapy: recent developments in autoimmunity and allergy

By Stemmer C. Guichard G.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 819-830

Informa Healthcare

Access to resources Recommend Favorite

Biologicals Dramatic Advances in the Treatment of Psoriasis

Current Pharmaceutical Design, Vol. 12, Iss. 8, 2006-03 ,pp. : 989-999

Bentham Science Publishers

Access to resources Recommend Favorite

Biologicals for psoriasis showing promise in long-term treatment

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

By Taghdisi Seyed Mohammad Abnous Khalil Mosaffa Fatemeh Behravan Javad

Journal of Drug Targeting, Vol. 18, Iss. 4, 2010-05 ,pp. : 277-281

Informa Healthcare

Access to resources Recommend Favorite

IL-17 targeted therapies for psoriasis

By Chiricozzi Andrea Krueger James G

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 993-1005

Informa Healthcare

Access to resources Recommend Favorite